Create

Sign in to ReadmeX

or

How we handle your data: Privacy Policy

ReadmeX

Your AI reading companion

What would you like to catch up on?

Pick a briefing, or ask your own question.

Your community and people briefings stay personal to you.

NHS England

AI overview

Sign in and the AI will write an overview from our coverage.

Headlines · 2

  1. 29 NHS trusts dispute Palantir platform benefit claims

    The Guardian, as summarized by The Next Web, reported that 29 NHS hospital trusts listed by NHS England as benefiting from Palantir’s data platform said the system was not live or that they used none of its applications. NHS England says 142 trusts are live on the platform and 137 report benefits, including trusts using it only for back-office data submission, while Palantir says participating trusts recorded 117,000 additional operations. The responses came from more than 100 freedom-of-information requests filed by Medact; The Next Web said it had not independently verified them.

    The Next Web · 🔥 0
  2. NHS South East rolls out DERM skin cancer AI that can discharge patients on its own

    Skin Analytics' DERM goes live across all 18 NHS trusts in south-east England from this autumn, covering another 9 million people over three years; the company calls it the largest deployment of autonomous medical AI in NHS history. DERM analyses images of a lesion taken after a suspected skin cancer referral and, when it judges the lesion benign, lets the NHS discharge the patient at the triage stage, while higher-risk cases are sent faster to a specialist. Skin Analytics says DERM is the first and only AI certified for autonomous use under a Class III CE mark, and reports it has assessed more than 250,000 patients and found over 25,000 cancers, with its own monitoring data putting skin cancer rule-out at 99.5% and detection at about 98%.

    The Next Web · 🔥 0

Experience and discussion from the community

Share my NHS England experienceAsk about NHS England

Nobody has shared their experience with NHS England yet.